These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 27569582)
1. GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. Ye QH; Zhu WW; Zhang JB; Qin Y; Lu M; Lin GL; Guo L; Zhang B; Lin ZH; Roessler S; Forgues M; Jia HL; Lu L; Zhang XF; Lian BF; Xie L; Dong QZ; Tang ZY; Wang XW; Qin LX Cancer Cell; 2016 Sep; 30(3):444-458. PubMed ID: 27569582 [TBL] [Abstract][Full Text] [Related]
2. GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma. Xie P; Wu M; Wang H; Zhang B; Zhang Z; Yan J; Yu M; Yu Q; Zhao Y; Huang D; Xu M; Xu W; Li H; Xu Y; Xiao Y; Guo L Oncogene; 2024 Oct; 43(42):3108-3120. PubMed ID: 39251847 [TBL] [Abstract][Full Text] [Related]
3. GOLM1-regulated EGFR/RTK recycling is a novel target for combating HCC metastasis. Zhu W; Qin L Sci China Life Sci; 2017 Jan; 60(1):98-101. PubMed ID: 27858335 [No Abstract] [Full Text] [Related]
4. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation. Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711 [TBL] [Abstract][Full Text] [Related]
5. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma. Chen MH; Jan YH; Chang PM; Chuang YJ; Yeh YC; Lei HJ; Hsiao M; Huang SF; Huang CY; Chau GY Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S616-24. PubMed ID: 23838921 [TBL] [Abstract][Full Text] [Related]
6. Tropomodulin 3 modulates EGFR-PI3K-AKT signaling to drive hepatocellular carcinoma metastasis. Zheng H; Yang Y; Hong YG; Wang MC; Yuan SX; Wang ZG; Bi FR; Hao LQ; Yan HL; Zhou WP Mol Carcinog; 2019 Oct; 58(10):1897-1907. PubMed ID: 31313392 [TBL] [Abstract][Full Text] [Related]
7. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma. Shao WQ; Zhu WW; Luo MJ; Fan MH; Li Q; Wang SH; Lin ZF; Zhao J; Zheng Y; Dong QZ; Lu L; Jia HL; Zhang JB; Lu M; Chen JH; Qin LX Cell Rep; 2022 Apr; 39(3):110712. PubMed ID: 35443161 [TBL] [Abstract][Full Text] [Related]
9. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma. Li KS; Zhu XD; Liu HD; Zhang SZ; Li XL; Xiao N; Liu XF; Xu B; Lei M; Zhang YY; Shi WK; Cao MQ; Xu YF; Tang ZY; Sun HC Cell Death Dis; 2020 May; 11(5):335. PubMed ID: 32382041 [TBL] [Abstract][Full Text] [Related]
10. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745 [TBL] [Abstract][Full Text] [Related]
12. Identification of GOLM1 as a positively regulator of tumor metastasis by regulating MMP13 in gastric carcinoma. Li XM; Cao LL Cancer Biomark; 2019; 26(4):421-430. PubMed ID: 31640085 [TBL] [Abstract][Full Text] [Related]
13. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression. Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789 [TBL] [Abstract][Full Text] [Related]
14. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma. Xiang Y; Wang Q; Guo Y; Ge H; Fu Y; Wang X; Tao L J Exp Clin Cancer Res; 2019 Apr; 38(1):145. PubMed ID: 30947731 [TBL] [Abstract][Full Text] [Related]
15. UNC50 prompts G1/S transition and proliferation in HCC by regulation of epidermal growth factor receptor trafficking. Fang Z; Zhou L; Jiang S; Cao L; Yu L PLoS One; 2015; 10(3):e0119338. PubMed ID: 25738771 [TBL] [Abstract][Full Text] [Related]
16. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076 [TBL] [Abstract][Full Text] [Related]
18. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma. Shali S; Yu J; Zhang X; Wang X; Jin Y; Su M; Liao X; Yu J; Zhi X; Zhou P J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547 [TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation. Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121 [TBL] [Abstract][Full Text] [Related]
20. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]